Immunitybio Inc
NASDAQ:IBRX
Immunitybio Inc
NASDAQ:IBRX
Price:
7.215
USD
8.33%
Market Cap:
$7.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Immunitybio Inc
NASDAQ:IBRX
|
US |
|
S
|
Swarna Securities Ltd
BSE:531003
|
IN |
|
R
|
RFM Corp
XPHS:RFM
|
PH |
|
B
|
Barrick Gold Corp
NYSE:GOLD
|
CA |
|
W
|
Wheeler Real Estate Investment Trust Inc
NASDAQ:WHLR
|
US |
|
E
|
EBOS Group Ltd
OTC:EBOSY
|
AU |
|
P
|
PJ Metal Co Ltd
KOSDAQ:128660
|
KR |
|
Lightspeed Commerce Inc
TSX:LSPD
|
CA |
|
Akshar Spintex Ltd
NSE:AKSHAR
|
IN |
|
Nano One Materials Corp
TSX:NANO
|
CA |
|
Canadian Tire Corporation Ltd
TSX:CTC.A
|
CA |
Multiples-Based Value
The
Multiples-Based Value for
Immunitybio Inc (IBRX)
under the Base Case is
hidden
USD.
Compared with the current market price of 7.215 USD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
IBRX Multiples-Based Value
LOCKED
Multiples Across Competitors
IBRX Competitors Multiples
Immunitybio Inc Competitors
Immunitybio Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Immunitybio Inc
NASDAQ:IBRX
|
6.7B USD | 65.5 | -21.1 | -34.5 | -32.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.8B USD | 6.3 | 91.4 | 15.1 | 21 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
361.6B USD | 111.3 | -1 738.3 | 16 147.7 | -1 823.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.1B USD | 5.2 | 24.6 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.2B USD | 5.8 | 20.1 | 12.6 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.6B USD | 9.4 | 28.6 | 21.5 | 22.5 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD | 5.7 | 18.1 | 13.5 | 15.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.9B AUD | 3.1 | 34.8 | 11.5 | 14.4 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
